LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

LLY

1,073.71

-0.24%↓

JNJ

207.38

-0.2%↓

ABBV

230

-0.06%↓

UNH

329.54

+0.55%↑

AZN

92.78

+0.3%↑

Search

Penumbra Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

315.02 -0.32

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

312.53

Max

316

Pagrindiniai rodikliai

By Trading Economics

Pajamos

581K

46M

Pardavimai

15M

355M

P/E

Sektoriaus vid.

76.393

78.892

Pelno marža

12.927

Darbuotojai

4,500

EBITDA

4M

55M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+7.01% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.7B

13B

Ankstesnė atidarymo kaina

315.34

Ankstesnė uždarymo kaina

315.02

Naujienos nuotaikos

By Acuity

50%

50%

152 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Penumbra Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-24 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

2025-12-24 14:57; UTC

Įsigijimai, susijungimai, perėmimai

Accenture to Acquire Cabel Industry from Fibonacci Group

2025-12-25 23:42; UTC

Rinkos pokalbiai

Nikkei May Trade in Range; Yen in Focus -- Market Talk

2025-12-25 23:40; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

2025-12-25 00:20; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

2025-12-24 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

2025-12-24 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

2025-12-24 19:35; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-24 19:35; UTC

Rinkos pokalbiai

Treasury Yields Decline Ahead of Christmas -- Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

2025-12-24 19:06; UTC

Rinkos pokalbiai

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

2025-12-24 19:03; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-24 17:08; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 16:53; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- WSJ

2025-12-24 16:31; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

2025-12-24 16:28; UTC

Įsigijimai, susijungimai, perėmimai

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

2025-12-24 16:17; UTC

Rinkos pokalbiai

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

2025-12-24 15:33; UTC

Įsigijimai, susijungimai, perėmimai

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

2025-12-24 15:30; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 15:19; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:49; UTC

Įsigijimai, susijungimai, perėmimai

Mexico's Ollamani Sells Stake in Azteca Stadium

2025-12-24 14:19; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

2025-12-24 14:08; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:06; UTC

Rinkos pokalbiai

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

2025-12-24 13:24; UTC

Rinkos pokalbiai

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

2025-12-24 12:59; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 12:51; UTC

Įsigijimai, susijungimai, perėmimai

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Penumbra Inc Prognozė

Kainos tikslas

By TipRanks

7.01% į viršų

12 mėnesių prognozė

Vidutinis 338 USD  7.01%

Aukščiausias 388 USD

Žemiausias 266 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Penumbra Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

13

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

288.28 / 292.9394Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

152 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat